|Articles|February 13, 2020

Managed Care Review of Unmet Medical Needs, New Treatments, and Health Economics Associated with Schizophrenia - Payer Forum

https://www.pharmacytimes.org/on-demand/a-managed-care-review-of-unmet-medical-needs-new-treatments-and-health-economics-associated-with-schizophrenia

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Car exhaust | Image Credit: olando - stock.adobe.com

FITs Offer Lowest Environmental Footprint Among CRC Screening Options

ByBrooke McCormick

August 17th 2026

COVID | Image credit: phonlamaiphoto - stock.adobe.com

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

BySabrina McCrear

August 17th 2026

Alzheimer | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com

Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care

BySkylar Jeremias

August 17th 2026

Zanubrutinib | Image Credit: © luchschenF-stock.adobe.com

Zanubrutinib Outlasting Acalabrutinib in CLL

ByMaggie L. Shaw

August 17th 2026

Brittany G. Craiglow, MD, FAAD in part 3 of an AJMC interview

Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

BySkylar Jeremias,Brittany G. Craiglow, MD, FAAD

August 17th 2026

Managed Care Review of Unmet Medical Needs, New Treatments, and Health Economics Associated with Schizophrenia - Payer Forum

Related Content

FITs Offer Lowest Environmental Footprint Among CRC Screening Options

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care

Zanubrutinib Outlasting Acalabrutinib in CLL

Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

Trending on AJMC

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

ICER Draft Flags High Cost of New Hypertension Drug Class

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD

FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication